risedronic acid has been researched along with Arthritis, Rheumatoid in 13 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effects of vitamin K2 (Vit K2) alone or in combination with etidronate and risedronate on bone loss, osteoclast induction, and inflammation in patients with rheumatoid arthritis (RA)." | 9.13 | Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results. ( Morishita, M; Nagashima, M; Takahashi, H; Takenouchi, K; Wauke, K, 2008) |
| "To investigate the effects of vitamin K2 (Vit K2) alone or in combination with etidronate and risedronate on bone loss, osteoclast induction, and inflammation in patients with rheumatoid arthritis (RA)." | 5.13 | Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results. ( Morishita, M; Nagashima, M; Takahashi, H; Takenouchi, K; Wauke, K, 2008) |
| " Incident of non-traumatic spine fractures and adverse events were tracked as safety endpoints." | 3.01 | Efficacy and safety of sodium RISedronate for glucocorticoid-induced OsTeoporosis with rheumaTOid arthritis (RISOTTO study): A multicentre, double-blind, randomized, placebo-controlled trial. ( Amasaki, Y; Atsumi, T; Fujieda, Y; Fukaya, S; Furukawa, S; Furusaki, A; Horita, T; Iwasaki, N; Kasahara, H; Katayama, K; Kato, M; Katsumata, K; Kurita, T; Matsui, K; Nishimoto, N; Oku, K; Sagawa, A; Shane, P; Takahata, M; Takeda, T; Takeuchi, K; Tanimura, K; Tsutsumi, A; Yasuda, S, 2021) |
| "Osteoporosis is a common adverse reaction induced by glucocorticoid treatment." | 2.73 | Comparative studies on effect of risedronate and alfacalcidol against glucocorticoid-induced osteoporosis in rheumatoid arthritic patients. ( Ichimura, A; Iwata, H; Nakajima, T; Ochiai, H; Takagi, H; Toriyama, T; Tsuchiya, H; Yamada, S, 2007) |
| "Breast or prostate cancer patients were treated with zoledronate." | 1.39 | Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic. ( Fujimoto, Y; Muramatsu, K; Murayama, M; Nakata, E; Nomura, T; Ogane, S; Sekine, R; Shibahara, T; Shibui, T; Uchiyama, T; Watanabe, A; Yakushiji, T; Yamamoto, N, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Fujieda, Y | 1 |
| Horita, T | 1 |
| Nishimoto, N | 1 |
| Tanimura, K | 1 |
| Amasaki, Y | 1 |
| Kasahara, H | 1 |
| Furukawa, S | 1 |
| Takeda, T | 1 |
| Fukaya, S | 1 |
| Matsui, K | 1 |
| Tsutsumi, A | 1 |
| Furusaki, A | 1 |
| Sagawa, A | 1 |
| Katayama, K | 2 |
| Takeuchi, K | 1 |
| Katsumata, K | 1 |
| Kurita, T | 1 |
| Shane, P | 1 |
| Kato, M | 1 |
| Oku, K | 1 |
| Yasuda, S | 1 |
| Takahata, M | 1 |
| Iwasaki, N | 1 |
| Atsumi, T | 1 |
| Kumagai, K | 1 |
| Harigane, K | 1 |
| Kusayama, Y | 1 |
| Tezuka, T | 1 |
| Choe, H | 1 |
| Inaba, Y | 1 |
| Saito, T | 1 |
| Nomura, T | 1 |
| Shibahara, T | 1 |
| Uchiyama, T | 1 |
| Yamamoto, N | 1 |
| Shibui, T | 1 |
| Yakushiji, T | 1 |
| Watanabe, A | 1 |
| Muramatsu, K | 1 |
| Ogane, S | 1 |
| Murayama, M | 1 |
| Sekine, R | 1 |
| Nakata, E | 1 |
| Fujimoto, Y | 1 |
| Laurent, AJ | 1 |
| Bindslev, N | 1 |
| Johansson, B | 1 |
| Berg, L | 1 |
| Koh, JH | 1 |
| Myong, JP | 1 |
| Jung, SM | 1 |
| Lee, J | 1 |
| Kwok, SK | 1 |
| Park, SH | 1 |
| Ju, JH | 1 |
| Ebina, K | 1 |
| Noguchi, T | 1 |
| Hirao, M | 1 |
| Hashimoto, J | 1 |
| Kaneshiro, S | 1 |
| Yukioka, M | 1 |
| Yoshikawa, H | 1 |
| Lange, U | 1 |
| Illgner, U | 1 |
| Teichmann, J | 1 |
| Schleenbecker, H | 1 |
| Cruse, LM | 1 |
| Valeriano, J | 1 |
| Vasey, FB | 1 |
| Carter, JD | 1 |
| Yamada, S | 1 |
| Takagi, H | 1 |
| Tsuchiya, H | 1 |
| Nakajima, T | 1 |
| Ochiai, H | 1 |
| Ichimura, A | 1 |
| Iwata, H | 1 |
| Toriyama, T | 1 |
| Nakayama, H | 1 |
| Morishita, M | 1 |
| Nagashima, M | 1 |
| Wauke, K | 1 |
| Takahashi, H | 1 |
| Takenouchi, K | 1 |
| Matsuno, T | 1 |
| Eastell, R | 1 |
| Devogelaer, JP | 1 |
| Peel, NF | 1 |
| Chines, AA | 1 |
| Bax, DE | 1 |
| Sacco-Gibson, N | 1 |
| Nagant de Deuxchaisnes, C | 1 |
| Russell, RG | 1 |
1 review available for risedronic acid and Arthritis, Rheumatoid
| Article | Year |
|---|---|
[Osteoporosis in the patients with rheumatoid arthritis (3) : the efficacy and the selection of the osteoporosis therapeutic drug].
Topics: Alendronate; Arthritis, Rheumatoid; Bone Density Conservation Agents; Etidronic Acid; Humans; Osteop | 2007 |
7 trials available for risedronic acid and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Efficacy and safety of sodium RISedronate for glucocorticoid-induced OsTeoporosis with rheumaTOid arthritis (RISOTTO study): A multicentre, double-blind, randomized, placebo-controlled trial.
Topics: Aged; Arthritis, Rheumatoid; Bone Density; Bone Density Conservation Agents; Double-Blind Method; Fe | 2021 |
Effects of once-monthly minodronate versus risedronate in osteoporosis patients with rheumatoid arthritis: a 12-month randomized head-to-head comparison.
Topics: Administration, Oral; Aged; Arthritis, Rheumatoid; Bone Density; Bone Density Conservation Agents; B | 2018 |
Skeletal benefit after one year of risedronate therapy in patients with rheumatoid arthritis and glucocorticoid-induced osteoporosis: a prospective study.
Topics: Alkaline Phosphatase; Arthritis, Rheumatoid; Bone and Bones; C-Reactive Protein; Cross-Linking Reage | 2004 |
Comparative studies on effect of risedronate and alfacalcidol against glucocorticoid-induced osteoporosis in rheumatoid arthritic patients.
Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Biomarkers; Bone Density; Bone Density Conservation | 2007 |
Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results.
Topics: Aged; Alkaline Phosphatase; Arthritis, Rheumatoid; Bone Density; Bone Density Conservation Agents; C | 2008 |
Effects of bisphosphonates on fracture incidence and bone metabolism in rheumatoid arthritis patients in general practice taking long-term corticosteroid therapy: a retrospective study.
Topics: Aged; Alendronate; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Bone and Bones; Bone Density Con | 2008 |
Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patients.
Topics: Administration, Oral; Aged; Arthritis, Rheumatoid; Bone Density; Calcium Channel Blockers; Double-Bl | 2000 |
5 other studies available for risedronic acid and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Alendronate; Anti-Bacterial | 2013 |
Synergistic effects of ethanol and isopentenyl pyrophosphate on expansion of γδ T cells in synovial fluid from patients with arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Cell Proliferation; Cell Survival; Drug Synergism; Ethanol; Etid | 2014 |
Atypical Femoral Fracture in Rheumatoid Arthritis Patients Treated With Bisphosphonates: A Nested Case-Control Study.
Topics: Absorptiometry, Photon; Aged; Alendronate; Arthritis, Rheumatoid; Bone Density; Bone Density Conserv | 2016 |
Effects of switching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis: a 12-month prospective study.
Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Alendronate; Arthritis, Rheumatoid; Biomarke | 2016 |
Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
Topics: Aged; Aged, 80 and over; Alendronate; Arthritis, Rheumatoid; Bone Density; Bone Density Conservation | 2006 |